China Cancer Test Market Research, Analysis and Forecast 2022

As per report analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022. In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness against cancer and the promotion of healthy lifestyle have also been carried out actively.

To read the complete report, click the link below :

Growing Lung Cancer out of 26 Cancer Cases Studied in the Report

Cancer is one of the most significant public health burdens in China. China has exceptional number of lung cancer diagnoses and deaths than any other part of the world. The problem will keep mounting in near future as China’ air pollution goes mostly unchecked. In total 26 types of Cancer market and number of cases have been studied in the report.

Lung Cancer dominates the China Oncology (Cancer) Screening Tests Market and Volume

In Male: Lung Cancer is the most predominant cancer, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order).

In Female: Other than Lung, Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma.

High Cancer Mortality Rates

Cancer mortality rates in China have been rising rapidly over the past three decades. In urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

Research report titled “China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022” studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

1. China Cancer (Oncology) Screening Tests Market & Forecast

• Male
• Female

2. China Cancer (Oncology) Screening Tests Volume & Forecast

• Male
• Female

3. China Cancer (Oncology) Mortality Rate

All the 26 Cancer Market & Cases Studied in the Report are as Follows:

1. Lip, oral cavity, & pharynx (except nasopharynx)
2. Nasopharynx
3. Esophagus
4. Stomach
5. Colorectum
6. Liver
7. Gallbladder
8. Pancreas
9. Larynx
10. Lung
11. Other thoracic organs
12. Bone
13. Melanoma of the skin
14. Breast
15. Cervix
16. Uterus
17. Ovary
18. Prostate
19. Testis
20. Kidney
21. Bladder
22. Brain, CNS
23. Thyroid
24. Lymphoma
25. Leukemia
26. All other sites and unspecified

Table of Contents

1. Research Findings

2. China – Cancer Test Market (2010 – 2022)

3. China – Cancer Test Volume (2010 – 2022)

4. China – Cancer Test Market Share (2010 – 2022)

5. China Oncology Test Market Share – Male Vs Female

6. China – Cancer Test Volume Share (2010 – 2022)

7. China Oncology Test Volume Share – Male Vs Female

Related Reports:- Prostate Cancer Market Reports

Contact Us
Market Reports on China

Contact No: India: +91 22 27810773

Follow us on : Twitter, Facebook, LinkedIn, Google Plus


Designed by
Powered by
%d bloggers like this: